Lexeo Therapeutics, Inc. - Common Stock (LXEO)

Historical Holders from Q4 2023 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
LXEO on Nasdaq
Shares outstanding
72,987,327
Price per share
$9.93
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
49,357,693
Holdings value
$327,711,484
% of all portfolios
0%
Share change
+7,102,557
Value change
+$52,680,419
Average buys %
+0%
Average sells %
-0%
Number of holders
109
Price from insider filings
$9.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lexeo Therapeutics, Inc. - Common Stock (LXEO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10% -12% $65,914,563 +$10,720,599 7,291,434 +19% JANUS HENDERSON GROUP PLC 28 Nov 2025
BALYASNY ASSET MANAGEMENT L.P. 10% 0% $35,820,947 -$19,594,175 5,394,721 -35% Balyasny Asset Management L.P. 30 Sep 2025
CITADEL ADVISORS LLC 9.6% $25,177,009 5,334,112 Kenneth Griffin 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P. 6.9% $33,200,000 5,000,000 RA Capital Management, L.P. 20 Oct 2025
Affinity Asset Advisors, LLC 7.8% $20,069,464 4,252,005 Affinity Healthcare Fund, LP 28 May 2025
Vestal Point Capital, LP 7.5% +25% $27,338,885 +$5,903,896 4,117,302 +28% Vestal Point Capital, LP 30 Sep 2025
Paradigm Biocapital Advisors LP 5% $33,047,991 3,671,999 Paradigm BioCapital Advisors LP 13 Nov 2025
Frazier Life Sciences Public Fund, L.P. 5.7% $14,506,764 3,073,467 Frazier Life Sciences Public Fund, L.P. 30 Jun 2025
Longitude Capital Partners IV, LLC 3.8% $18,362,130 2,765,381 Longitude Capital Partners IV, LLC 30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 3.2% -42% $15,362,583 -$3,470,396 2,313,642 -18% Millennium Management LLC 30 Sep 2025
MIZUHO FINANCIAL GROUP INC 6.6% +13% $3,944,499 +$496,367 2,203,631 +14% Mizuho Financial Group, Inc. 31 Mar 2025
BlackRock, Inc. 4% -25% $14,368,977 +$2,295,902 2,168,444 +19% BlackRock, Inc. 30 Sep 2025
EVENTIDE ASSET MANAGEMENT, LLC 3.7% $2,210,353 1,234,834 Eventide Asset Management, LLC 31 Dec 2024
Omega Fund VI, L.P. 3.6% $2,120,498 1,184,636 Omega Fund VI, L.P. 31 Dec 2024
D1 Capital Partners L.P. 2.9% $1,751,787 978,652 D1 Capital Partners L.P. 31 Mar 2025
Adage Capital Management, L.P. 0.7% -85% $425,936 -$3,529,275 237,953 -89% Adage Capital Management, L.P. 31 Mar 2025
As of 30 Sep 2025, Lexeo Therapeutics, Inc. - Common Stock (LXEO) has 109 institutional shareholders filing 13F forms. They hold 49,357,693 shares of 72,987,327 outstanding shares (68%) .

Top 25 institutional shareholders own 64% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 8.4% 6,105,527 +66% 0.02% $40,492,761
Frazier Life Sciences Management, L.P. 6.1% 4,424,725 0% 0.88% $29,380,174
Balyasny Asset Management L.P. 5.4% 3,913,788 -2.4% 0.05% $25,987,552
Affinity Asset Advisors, LLC 5.3% 3,870,527 +7.8% 2.4% $25,700,299
CITADEL ADVISORS LLC 5.1% 3,719,043 +3.1% 0.02% $24,694,446
Vestal Point Capital, LP 4.5% 3,250,000 +0.68% 0.98% $21,580,000
Woodline Partners LP 3.5% 2,572,162 0% 0.08% $17,079,156
MILLENNIUM MANAGEMENT LLC 3.2% 2,313,642 -18% 0.01% $15,362,583
VANGUARD GROUP INC 3.1% 2,226,290 +11% 0% $14,782,566
BlackRock, Inc. 3% 2,171,092 +19% 0% $14,416,051
Point72 Asset Management, L.P. 2.7% 1,941,849 +200% 0.03% $12,893,875
ADAR1 Capital Management, LLC 2.1% 1,531,953 +956% 1% $10,172,168
Blackstone Inc. 1.5% 1,124,922 0% 0.03% $7,469,482
D1 Capital Partners L.P. 1.3% 978,652 0% 0.07% $6,498,249
683 Capital Management, LLC 1.3% 922,662 0.56% $6,126,476
DIMENSIONAL FUND ADVISORS LP 1.3% 912,533 +1841% 0% $6,059,280
SILVERARC CAPITAL MANAGEMENT, LLC 1.1% 778,611 0.75% $5,169,977
GEODE CAPITAL MANAGEMENT, LLC 0.99% 721,881 +25% 0% $4,794,441
Siren, L.L.C. 0.83% 603,435 0% 0.16% $4,006,808
Ikarian Capital, LLC 0.78% 567,601 +3.2% 0.85% $3,768,870
STATE STREET CORP 0.75% 544,845 +6.2% 0% $3,617,771
Verition Fund Management LLC 0.57% 414,863 0% 0.02% $2,754,690
DAFNA Capital Management LLC 0.49% 358,083 -5.3% 0.59% $2,377,671
AQR CAPITAL MANAGEMENT LLC 0.48% 347,923 +84% 0% $2,310,208
UBS Group AG 0.34% 249,909 -8.1% 0% $1,659,395

Institutional Holders of Lexeo Therapeutics, Inc. - Common Stock (LXEO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 33,246 $324,020 +$186,315 $9.93 4
2025 Q3 49,357,693 $327,711,484 +$52,680,419 $6.64 109
2025 Q2 42,272,843 $169,997,165 +$59,022,466 $4.02 90
2025 Q1 28,007,948 $99,997,228 -$11,520,761 $3.47 88
2024 Q4 29,519,159 $194,193,437 -$4,086,063 $6.58 89
2024 Q3 29,735,114 $268,784,196 +$10,322,369 $9.04 67
2024 Q2 26,566,622 $426,105,242 +$55,254,661 $16.04 57
2024 Q1 23,119,889 $361,544,722 +$108,357,037 $15.68 54
2023 Q4 16,174,480 $217,090,546 +$216,963,240 $13.42 31